Jared S Jones, DO in Dillon, MT - Medicare Emergency Medicine

Jared S Jones, DO is a medicare enrolled "Emergency Medicine" physician in Dillon, Montana. His current practice location is 600 Mt Highway 91 S, Dillon, Montana. You can reach out to his office (for appointments etc.) via phone at (406) 683-3051.

Jared S Jones is licensed to practice in Montana (license number MED-PHYS-LIC-112777) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1316409477.

Contact Information

	Jared S Jones, DO
	600 Mt Highway 91 S, Dillon, MT 59725-7379
	(406) 683-3051
	Not Available

Physician's Profile

Full Name	Jared S Jones
Gender	Male
Speciality	Emergency Medicine
Location	600 Mt Highway 91 S, Dillon, Montana
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1316409477
Provider Enumeration Date: 04/05/2019
Last Update Date: 01/04/2023

Medicare PECOS Information:

PECOS PAC ID: 6507191806
Enrollment ID: I20220720002939

Medical Identifiers

Medical identifiers for Jared S Jones such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316409477	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	7715884-1204 (Utah)	Secondary
207P00000X	Emergency Medicine	MED-PHYS-LIC-112777 (Montana)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Jared S Jones allows following entities to bill medicare on his behalf.

Entity Name	Barrett Hospital Development Corporation
Entity Type	Part B Supplier - Hospital Department(s)
Entity Identifiers	NPI Number: 1396286480 PECOS PAC ID: 4082904487 Enrollment ID: O20170223001015

News Archive

Exercise is emerging as a new therapeutic weapon to tackle cancer

When individuals with breast or prostate cancer followed a moderate, home-based exercise program using resistance bands and walking, the patients had less fatigue during radiation treatments, greater strength and could walk farther and faster in only four weeks, researchers discovered in a pilot study.

Study points to need for improving pediatric benefits under the Affordable Care Act

An article published in the Health Affairs December issue is the first ever comprehensive analysis to investigate the Affordable Care Act's (ACA) Essential Health Benefit (EHB) as it relates to children. The study found that the EHB has resulted in a state-by-state patchwork of coverage for children and adolescents that has significant exclusions, particularly for children with developmental disabilities and other special health care needs.

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

iCo Therapeutics Inc., today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs.

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.

Combination of estrogen and MPA increases synapses in the prefrontal cortex

A new study of aged female rats found that long-term treatment with estrogen and a synthetic progesterone known as MPA increased levels of a protein marker of synapses in the prefrontal cortex, a brain region known to suffer significant losses in aging.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jared S Jones is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jared S Jones, DO 600 Mt Highway 91 S, Dillon, MT 59725-7379 Ph: (406) 683-3051	Jared S Jones, DO 600 Mt Highway 91 S, Dillon, MT 59725-7379 Ph: (406) 683-3051

News Archive

Exercise is emerging as a new therapeutic weapon to tackle cancer

Study points to need for improving pediatric benefits under the Affordable Care Act

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

iCo Therapeutics Inc., today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs.

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Combination of estrogen and MPA increases synapses in the prefrontal cortex

Emergency Medicine Doctors in Dillon, MT

Gregory J Moore, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3051
Ashly Ann Roby Parker, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Mt Highway 91 S, Dillon, MT 59725 Phone: 406-683-3000

Jared S Jones, DO - Medicare Emergency Medicine in Dillon, MT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Exercise is emerging as a new therapeutic weapon to tackle cancer

Study points to need for improving pediatric benefits under the Affordable Care Act

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Combination of estrogen and MPA increases synapses in the prefrontal cortex

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Exercise is emerging as a new therapeutic weapon to tackle cancer

Study points to need for improving pediatric benefits under the Affordable Care Act

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Combination of estrogen and MPA increases synapses in the prefrontal cortex

Emergency Medicine Doctors in Dillon, MT